Methylphenidate response in prenatal cocaine-exposed rats: a behavioral and brain functional study

Area of Science:

• Neuroscience
• Developmental Neuroscience
• Pharmacology

Background:

• Prenatal cocaine exposure is linked to attention deficits in children.
• Methylphenidate (MPD) is a common treatment for attention disorders.
• Understanding MPD's effects on the developing brain after prenatal drug exposure is crucial.

Purpose of the Study:

• To investigate the impact of prenatal cocaine exposure on brain glucose metabolism in response to methylphenidate (MPD) using a rodent model.
• To assess how prenatal cocaine affects the relationship between brain activity and behavior under MPD challenge.

Main Methods:

• Pregnant rats received cocaine or vehicle, and offspring were treated with MPD or saline during development.
• The 2-deoxyglucose (2DG) method quantified glucose metabolism in 79 brain regions of freely behaving offspring.
• Mixed linear models analyzed glucose metabolism in mesolimbic and motor circuits, correlating it with MPD-induced behaviors.

Main Results:

• MPD significantly increased glucose metabolism across most brain regions (15-30%) irrespective of prenatal treatment.
• Prenatal cocaine exposure showed minimal overall effects on brain glucose metabolism.
• A reduced MPD response in the nucleus accumbens was observed in cocaine-exposed offspring, varying with rostral/caudal location.
• Prenatal cocaine altered the relationship between regional metabolism and MPD-induced behaviors (stereotypy, locomotion) in a sex-specific manner.

Conclusions:

• Prenatal cocaine exposure has limited direct effects on brain metabolic activity, even under pharmacological challenge.
• Prenatal cocaine significantly disrupts the coupling between brain metabolism and behavior, particularly in response to methylphenidate.
• These findings highlight critical neurodevelopmental consequences of prenatal cocaine exposure on brain-behavior relationships.